SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001787306-22-000030
Filing Date
2022-05-05
Accepted
2022-05-05 16:04:39
Documents
14
Period of Report
2022-05-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K arqt-20220505.htm   iXBRL 8-K 36496
2 EX-99.1 pressreleaseex991q12022.htm EX-99.1 76866
6 a1a82a.jpg GRAPHIC 25530
  Complete submission text file 0001787306-22-000030.txt   300788

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT arqt-20220505.xsd EX-101.SCH 1887
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT arqt-20220505_lab.xml EX-101.LAB 26153
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT arqt-20220505_pre.xml EX-101.PRE 13571
8 EXTRACTED XBRL INSTANCE DOCUMENT arqt-20220505_htm.xml XML 11302
Mailing Address 3027 TOWNSGATE ROAD SUITE 300 WESTLAKE VILLAGE CA 91361
Business Address 3027 TOWNSGATE ROAD SUITE 300 WESTLAKE VILLAGE CA 91361 805-418-5006
Arcutis Biotherapeutics, Inc. (Filer) CIK: 0001787306 (see all company filings)

IRS No.: 812974255 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39186 | Film No.: 22896115
SIC: 2834 Pharmaceutical Preparations